Home

We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases

To learn more about Erytech's phase 3 clinical trial in pancreatic cancer

To learn more about Erytech's phase 2 clinical trial in Triple Negative Breast Cancer

Learn about the treatment landscape and unmet medical needs in pancreatic cancer. View the webcast of our KOL event with Dr. Hidalgo